Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations
Mol Genet Metab Rep. 2024 Jun 28;40:101113. doi: 10.1016/j.ymgmr.2024.101113. eCollection 2024 Sep. ABSTRACT Fluoxetine has been identified as a potential treatment for mucopolysaccharidosis IIIA (MPS …